Advertisements
Read Time:7 Second
Breast cancer patients may now benefit from two of AstraZeneca’s existing therapies. The EU has recommended lynparza and enhertu to treat high-risk breast cancer.
Happy
0
0 %
Sad
0
0 %
Excited
0
0 %
Sleepy
0
0 %
Angry
0
0 %
Surprise
0
0 %